Figure 3From: Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expressionSurvival rates of four primary cell lines treated with different amounts of cisplatin. Rates are referred to day 3 after treatment in the acute cytotoxicity assay.Back to article page